Health utility values associated with diabetic retinopathy.
about
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaCost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project.Cost-effectiveness of treatment of diabetic macular edema.Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15-34 years - a Swedish population-based study using EQ-5D.Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.A review of generic preference-based measures of health-related quality of life in visual disordersValidity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore populationThe Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edemaThe long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohortCosts and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY).The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015.Perceived Barriers and Potential Strategies to Improve Self-Management Among Adults with Type 2 Diabetes: A Community-Engaged Research Approach.Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.Visual and health outcomes, measured with the activity inventory and the EQ-5D, in visual impairment.The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy.Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.Cost-effectiveness of cataract surgery in Japan.
P2860
Q24202071-5E1A695D-FD54-4343-BBE0-5C48C78FDD15Q31049802-08FD042E-C4CD-4CFE-8E4D-222452A58601Q33454384-B49ED05A-BA1C-49FA-ADBB-11ACEF7B9065Q33606611-8EDD4ED6-FEAE-4AB7-A511-91456C12F86EQ34680778-932E0E6A-81EB-4448-8308-050687F9E4A1Q35059037-71F5B57B-C4DF-4CFD-A60A-A53E8C99FD32Q35713188-C36B3618-33D7-4977-8CE4-1F4452A3A2B5Q35820332-69F5D973-B01C-4C17-B09F-DC526B2BE797Q36134684-28C19AD3-28CD-49BD-B0B6-B99CA541260FQ36689823-35BB2532-86A5-4117-9753-EBCA40CAA8B4Q37193587-CAFBF627-7349-4720-8205-6DEEAC259F40Q37699938-97162219-594B-4053-B464-DEF5B1B9D94BQ37851559-AF31E849-8A17-4CE6-A3ED-42C4A4E1A891Q37862622-25763BD0-852E-47BE-8B42-BBD81771AAA2Q38673270-D2F1083C-DC31-4B5E-9697-E18B87C8B3E3Q38900450-2A852402-7D69-40FD-A90C-3301178E4549Q39867113-06C74CBE-920C-4AB7-8290-F3B8F6D7C1D3Q47567326-213F559E-7E53-40B6-96C1-0E9D7DC794FAQ48000856-2F13DE3B-057A-4B2F-9065-A3FEF7B771F9Q48450020-3841B715-CB0C-41EB-A65A-B2899917B47BQ48643706-CE5B4EB3-2032-4221-94CB-614B7741CC63
P2860
Health utility values associated with diabetic retinopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Health utility values associated with diabetic retinopathy.
@en
Health utility values associated with diabetic retinopathy.
@nl
type
label
Health utility values associated with diabetic retinopathy.
@en
Health utility values associated with diabetic retinopathy.
@nl
prefLabel
Health utility values associated with diabetic retinopathy.
@en
Health utility values associated with diabetic retinopathy.
@nl
P2093
P2860
P1433
P1476
Health utility values associated with diabetic retinopathy.
@en
P2093
P2860
P304
P356
10.1111/J.1464-5491.2008.02430.X
P577
2008-03-13T00:00:00Z